These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 38530845)
1. Differential carbonic anhydrase activities control EBV-induced B-cell transformation and lytic cycle reactivation. Malik S; Biswas J; Sarkar P; Nag S; Gain C; Ghosh Roy S; Bhattacharya B; Ghosh D; Saha A PLoS Pathog; 2024 Mar; 20(3):e1011998. PubMed ID: 38530845 [TBL] [Abstract][Full Text] [Related]
2. The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1. Robinson AR; Kwek SS; Kenney SC PLoS Pathog; 2012 Feb; 8(2):e1002516. PubMed ID: 22346751 [TBL] [Abstract][Full Text] [Related]
3. Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions. Rowe M; Raithatha S; Shannon-Lowe C J Virol; 2014 Oct; 88(20):12065-76. PubMed ID: 25122803 [TBL] [Abstract][Full Text] [Related]
4. hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: implications for EBV-driven lymphomagenesis. Terrin L; Dolcetti R; Corradini I; Indraccolo S; Dal Col J; Bertorelle R; Bonaldi L; Esposito G; De Rossi A Int J Cancer; 2007 Aug; 121(3):576-87. PubMed ID: 17417773 [TBL] [Abstract][Full Text] [Related]
5. The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites. Kalla M; Göbel C; Hammerschmidt W J Virol; 2012 Jan; 86(1):447-58. PubMed ID: 22031942 [TBL] [Abstract][Full Text] [Related]
6. B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection. Romero-Masters JC; Huebner SM; Ohashi M; Bristol JA; Benner BE; Barlow EA; Turk GL; Nelson SE; Baiu DC; Van Sciver N; Ranheim EA; Gumperz J; Sherer NM; Farrell PJ; Johannsen EC; Kenney SC PLoS Pathog; 2020 Feb; 16(2):e1008365. PubMed ID: 32059024 [TBL] [Abstract][Full Text] [Related]
7. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters. Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866 [TBL] [Abstract][Full Text] [Related]
8. Nascent Transcriptomics Reveal Cellular Prolytic Factors Upregulated Upstream of the Latent-to-Lytic Switch Protein of Epstein-Barr Virus. Frey TR; Brathwaite J; Li X; Burgula S; Akinyemi IA; Agarwal S; Burton EM; Ljungman M; McIntosh MT; Bhaduri-McIntosh S J Virol; 2020 Mar; 94(7):. PubMed ID: 31941784 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. Kraus RJ; Yu X; Cordes BA; Sathiamoorthi S; Iempridee T; Nawandar DM; Ma S; Romero-Masters JC; McChesney KG; Lin Z; Makielski KR; Lee DL; Lambert PF; Johannsen EC; Kenney SC; Mertz JE PLoS Pathog; 2017 Jun; 13(6):e1006404. PubMed ID: 28617871 [TBL] [Abstract][Full Text] [Related]
10. Ceramide promotes lytic reactivation of Epstein-Barr virus in gastric carcinoma. Kim JY; Min YJ; Lee M-H; An YR; Ashktorab H; Smoot DT; Kwon SW; Lee SK J Virol; 2024 Feb; 98(2):e0177623. PubMed ID: 38197630 [TBL] [Abstract][Full Text] [Related]
11. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation. Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE mBio; 2020 Oct; 11(5):. PubMed ID: 33109754 [TBL] [Abstract][Full Text] [Related]
13. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency. Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393 [TBL] [Abstract][Full Text] [Related]
15. PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter. Lupey-Green LN; Moquin SA; Martin KA; McDevitt SM; Hulse M; Caruso LB; Pomerantz RT; Miranda JL; Tempera I Virology; 2017 Jul; 507():220-230. PubMed ID: 28456021 [TBL] [Abstract][Full Text] [Related]
16. Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus. Yu X; McCarthy PJ; Wang Z; Gorlen DA; Mertz JE J Virol; 2012 Aug; 86(15):8086-96. PubMed ID: 22623769 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of IQGAP2 by EBV transactivator Rta and its influence on EBV life cycle. Lin KM; Weng LF; Chen SJ; Lin SJ; Tsai CH J Virol; 2023 Aug; 97(8):e0054023. PubMed ID: 37504571 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells. Iempridee T; Reusch JA; Riching A; Johannsen EC; Dovat S; Kenney SC; Mertz JE J Virol; 2014 May; 88(9):4811-27. PubMed ID: 24522918 [TBL] [Abstract][Full Text] [Related]
19. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation. Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047 [TBL] [Abstract][Full Text] [Related]
20. Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction. Lv DW; Zhang K; Li R PLoS Pathog; 2018 Jan; 14(1):e1006868. PubMed ID: 29357389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]